KAINOS LaboratoriesTSE:4556 39 EV-to-FCF is 11.72 as of Jul. 11, 2026, which is 59% above its 10-year median of 7.37. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 414 Medical Devices & Instruments companies, KAINOS Laboratories ranks better than 78.5% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, KAINOS Laboratories's Enterprise Value is 円6,401 Mil.
KAINOS Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円546 Mil. Therefore, KAINOS Laboratories's EV-to-FCF for today is 11.72.
The historical rank and industry rank for KAINOS Laboratories's EV-to-FCF or its related term are showing as below:
TSE:4556'
s EV-to-FCF Range Over the Past 10 Years
Min: 3.35 Med: 7.37 Max: 27.63
Current: 11.72
During the past 13 years, the highest EV-to-FCF of KAINOS Laboratories was 27.63. The lowest was 3.35. And the median was 7.37.
TSE:4556's EV-to-FCF is ranked better than 78.5% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.19
vs TSE:4556: 11.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
KAINOS Laboratories's PE Ratio (TTM) for today is calculated as:
KAINOS Laboratories's share price for today is 円2268.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KAINOS Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円105.161.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
KAINOS Laboratories EV-to-FCF Related Terms
KAINOS Laboratories EV-to-FCF Historical Data
* Premium members only.
The historical data trend for KAINOS Laboratories's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KAINOS Laboratories EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where KAINOS Laboratories's EV-to-FCF falls into.
KAINOS Laboratories's current Enterprise Value is 円6,401 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KAINOS Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円546 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAINOS Laboratories (TSE:4556) has a EV-to-FCF of 11.72 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on KAINOS Laboratories and its competitors. This is 59% above median its historical median of 7.37. Over the past decade, KAINOS Laboratories' EV-to-FCF has ranged from 3.35 to 27.63. According to the industry distribution chart, KAINOS Laboratories ranks #89 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 21.5%.
Is KAINOS Laboratories' EV-to-FCF too high?
KAINOS Laboratories' current EV-to-FCF of 11.72 is 59% above median its 10-year median of 7.37. Over the past 10 years, this metric has ranged from a low of 3.35 to a high of 27.63. The Medical Devices & Instruments industry median EV-to-FCF is 23.19. KAINOS Laboratories' value of 11.72 is 49.5% below this industry median. Based on the distribution chart, KAINOS Laboratories ranks #89 out of 414 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KAINOS Laboratories ranks #89 out of 414 companies for EV-to-FCF. This places KAINOS Laboratories in the top 22% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.19. KAINOS Laboratories' value of 11.72 is 49.5% below this benchmark. Historically, KAINOS Laboratories' own EV-to-FCF has ranged from 3.35 to 27.63 over the past decade. While the company's 10-year median is 7.37 vs. the industry median of 23.19, KAINOS Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.19, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KAINOS Laboratories's current EV-to-FCF of 11.72 is 49.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on KAINOS Laboratories and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KAINOS Laboratories's current EV-to-FCF is 11.72, which is 59% above median its own 10-year median of 7.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current EV-to-FCF is 11.72, which is 59% above median its 10-year median of 7.37 and 49.5% below the Medical Devices & Instruments industry median of 23.19. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current EV-to-FCF is 11.72 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?
Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued.
The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99.
GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.
Key valuation signals for TSE:4556:
EV-to-FCF: 11.72 (59% above median its 10-year median of 7.37)
GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
Industry Position: 49.5% below the Medical Devices & Instruments median (#89 of 414)
No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score
Get the complete analysis for TSE:4556
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4556 has been successfully added to your 
